Daniele Altomare, PhD; Frederik Barkhof, MD; Camilla Caprioglio, MS; et al.
open access
JAMA Neurol. 2023;80(6):548-557. doi:10.1001/jamaneurol.2023.0997
This randomized clinical trial compares data for the timing of amyloid positron emission tomography for patients with concerns about cognitive decline to determine its clinical effect early in the diagnostic workup (within 1 month).
Priya S. Kishnani, MD; Jordi Diaz-Manera, MD; Antonio Toscano, MD; et al.
open access
JAMA Neurol. 2023;80(6):558-567. doi:10.1001/jamaneurol.2023.0552
This randomized clinical trial extension evaluates efficacy and safety outcomes of avalglucosidase alfa treatment in patients with late-onset Pompe disease.
Julie Werenberg Dreier, PhD; Marte-Helene Bjørk, PhD; Silje Alvestad, PhD; et al.
free access
has audio
JAMA Neurol. 2023;80(6):568-577. doi:10.1001/jamaneurol.2023.0674
This cohort study of children of mothers with epilepsy examines whether prenatal exposure to common prenatal antiseizure medication is associated with a broad spectrum of psychiatric disorders in childhood and adolescence.
-
Podcast:
Prenatal Exposure to Antiseizure Medication and Psychiatric Disorders
Sattar Khoshkhoo, MD; Yilan Wang, BS; Yasmine Chahine, BS; et al.
open access
JAMA Neurol. 2023;80(6):578-587. doi:10.1001/jamaneurol.2023.0473
This genetic association study evaluates the association between pathogenic somatic variants in the hippocampus and mesial temporal lobe epilepsy.
Andreas Schulze-Bonhage, MD; Martin Hirsch, MD; Susanne Knake, MD; et al.
open access
JAMA Neurol. 2023;80(6):588-596. doi:10.1001/jamaneurol.2023.0066
This pooled analysis of 2 nonrandomized uncontrolled trials investigates the association between epicranial electrical focal cortex stimulation and seizure frequency in drug-refractory focal epilepsy.
Chris Moran, PhD; Mary E. Lacy, PhD; Rachel A. Whitmer, PhD; et al.
free access
JAMA Neurol. 2023;80(6):597-604. doi:10.1001/jamaneurol.2023.0697
This cohort study examines associations between cumulative exposure to various ranges of glycated hemoglobin concentrations and dementia risk among adults aged 50 years or older with type 2 diabetes.
Lucia Sinka; Laura Abraira, MD, PhD; Lukas L. Imbach, MD, MSc; et al.
free access
JAMA Neurol. 2023;80(6):605-613. doi:10.1001/jamaneurol.2023.0611
This cohort study examines data for patients with acute ischemic stroke to compare the risk of poststroke mortality and epilepsy between different types of acute symptomatic seizures.
Antoine Leuzy, PhD; Alexa Pichet Binette, PhD; Jacob W. Vogel, PhD; et al.
open access
JAMA Neurol. 2023;80(6):614-623. doi:10.1001/jamaneurol.2023.1067
This cohort study investigates if defining participant-level regions of interest improves sensitivity to tau accumulation on positron emission tomography compared with group-level regions of interest.
Caleb R. S. McEntire, MD; Anita Fletcher, MD; Michel Toledano, MD; et al.
free access
JAMA Neurol. 2023;80(6):624-633. doi:10.1001/jamaneurol.2023.0841
This case series examines data for patients from 8 US medical centers to determine and describe the characteristics associated with progressive multifocal leukoencephalopathy in the context of sarcoidosis, including neurological symptoms and changes seen on brain magnetic resonance imaging.
Jihun Kang, MD, PhD; Yeonghee Eun, MD, PhD; Wooyoung Jang, MD, PhD; et al.
free access
JAMA Neurol. 2023;80(6):634-641. doi:10.1001/jamaneurol.2023.0932
This cohort study evaluates the associations of rheumatoid arthritis and its seropositivity with subsequent Parkinson disease risk in a nationally representative Korean population.